CVE-2026-21980

CVE-2026-21980 is a medium-severity vulnerability in Oracle Life Sciences Central Coding with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Frequently asked questions

What is CVE-2026-21980?
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
How severe is CVE-2026-21980?
CVE-2026-21980 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2026-21980 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (8th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-21980?
CVE-2026-21980 affects Oracle Life Sciences Central Coding. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-21980?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-21980 have an EU (EUVD) identifier?
Yes. CVE-2026-21980 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-3532.
When was CVE-2026-21980 published?
CVE-2026-21980 was published on 2026-01-20 and last updated on 2026-06-17.

References

Affected products (1)